Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Phase III data show non-inferiority of doravirine and darunavir/ritonavir

Feb. 16, 2017

Research Council of Norway grant supports Bionor's development of Vacc-4x for HIV

Jan. 30, 2017

ViiV Healthcare UK identifies novel HIV integrase inhibitors

Jan. 30, 2017

First-in-human data for 10-1074 in HIV-1-infected individuals

Jan. 26, 2017

ViiV Healthcare UK presents novel HIV integrase inhibitors

Jan. 24, 2017

GeoVax begins new study of HIV vaccine

Jan. 24, 2017

Full phase I data reported for novel anti-HIV compound ABX-464

Jan. 20, 2017

NIAID initiates phase I trial of VRC07-523LS

Jan. 19, 2017

GlaxoSmithKline describes new indoleamine 2,3-dioxygenase 1 inhibitors

Jan. 18, 2017

Kyorin Pharmaceutical prepares and tests FPR2 agonists

Dec. 19, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...